Clinical Trial Update: Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and immunogenicity of commercial-scale consistency lots of a herpes simplex vaccine developed by GlaxoSmithKline has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex Infection

Drugs mentioned

• Herpes Simplex Vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED